Li Amy Y, Visser Brendan C, Dua Monica M
Division of Surgical Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Cancers (Basel). 2022 May 6;14(9):2312. doi: 10.3390/cancers14092312.
Complete surgical resection of pancreatic neuroendocrine tumors (pNETs) has been suggested as the only potentially curative treatment. A proportion of these tumors will present late during disease progression, and invade or encase surrounding vasculature; therefore, surgical treatment of locally advanced disease remains controversial. The role of surgery with vascular reconstruction in pNETs is not well defined, and there is considerable variability in the use of aggressive surgery for these tumors. Accurate preoperative assessment is critical to evaluate individual considerations, such as anatomical variants, areas and lengths of vessel involvement, proximal and distal targets, and collateralization secondary to the degree of occlusion. Surgical approaches to address pNETs with venous involvement may include thrombectomy, traditional vein reconstruction, a reconstruction-first approach, or mesocaval shunting. Although the amount of literature on pNETs with vascular reconstruction is limited to case reports and small institutional series, the last two decades of studies have demonstrated that aggressive resection of these tumors can be performed safely and with acceptable long-term survival.
胰腺神经内分泌肿瘤(pNETs)的完整手术切除被认为是唯一可能治愈的治疗方法。这些肿瘤中有一部分会在疾病进展后期出现,并侵犯或包裹周围血管;因此,局部晚期疾病的手术治疗仍存在争议。pNETs中血管重建手术的作用尚不明确,对于这些肿瘤采用积极手术的情况存在很大差异。准确的术前评估对于评估个体因素至关重要,例如解剖变异、血管受累的区域和长度、近端和远端靶点以及因闭塞程度导致的侧支循环。处理伴有静脉受累的pNETs的手术方法可能包括血栓切除术、传统静脉重建、先行重建法或肠系膜上腔静脉分流术。尽管关于血管重建的pNETs的文献数量仅限于病例报告和小型机构系列研究,但过去二十年的研究表明,对这些肿瘤进行积极切除可以安全地进行,并且长期生存率可以接受。